Kirk Kaminsky to Lead McKesson’s U.S.-Based Pharmaceutical Business
IRVING, TEXAS—April 15, 2019—McKesson Corporation (NYSE:MCK) today announced that Kirk Kaminsky will be the new president of McKesson’s U.S. Pharmaceutical […]
IRVING, TEXAS—April 15, 2019—McKesson Corporation (NYSE:MCK) today announced that Kirk Kaminsky will be the new president of McKesson’s U.S. Pharmaceutical […]
IRVING, TEXAS — April 10, 2019 — McKesson Corporation (NYSE:MCK) will release financial results for its fourth quarter ended March 31, 2019 […]
Company selects Google Cloud Platform to power next-gen innovation and expand artificial intelligence, machine learning, and data & analytics capabilitiesCollaboration […]
Edward Mueller assumes role as independent chair of McKesson’s Board of DirectorsIrving, Texas officially McKesson’s new global headquarters
SAN FRANCISCO, March 28, 2019—For the sixth straight year, McKesson Corporation is honored as one of the “Best Places to Work for […]
IRVING, Texas, March 26, 2019 — Registration is now open for McKesson ideaShare in Orlando from June 26-30, 2019. Pharmacists, […]
IRVING, TEXAS, March 26, 2019—iKnowMed℠, McKesson’s oncology practice electronic health record (EHR) system, has been named the top-ranked EHR platform […]
CARY, N.C. (March 21, 2019) — Biologics by McKesson continues to expand its capabilities as a specialty pharmacy expert in […]
IRVING, TEXAS and SEATTLE, March 5, 2019 — Global healthcare leader McKesson Corporation announces a collaboration with technology leader Navigating […]
Revenues of $56.2 billion for the third quarter, up 5% year over year.Third-quarter GAAP earnings per diluted share from continuing […]